SCHEMBL12840765

SCHEMBL12840765

Cc1c(C(=O)NC(=S)Nc2ccc(C(=O)O)cc2)sc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.55
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ TDP1 Q9NUW8 4/20 0.55
▸ PKM P14618 1/20 0.55
▸ CRHBP P24387 1/20 0.55
▸ CRHR2 Q13324 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ MAPT P10636 6/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ HTT P42858 1/20 0.54
▸ MEN1 O00255 4/20 0.52
▸ POLB P06746 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ RXFP1 Q9HBX9 3/20 0.51
▸ PRNP P04156 2/20 0.51
▸ F10 P00742 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14136957 0.92 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KMT2ARAB9APKM
SCHEMBL12767900 0.86 MAPT (0.69) ALDH1A1SMN1; SMN2KMT2ARAB9ATDP1
SCHEMBL14706510 0.83 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KMT2ARAB9ATDP1
SCHEMBL14096502 0.77 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2KMT2ARAB9ATDP1
SCHEMBL31321777 0.75 ALDH1A1 (0.85) ALDH1A1SMN1; SMN2KMT2ARAB9ATDP1
SCHEMBL11955716 0.74 F10 (0.55) SMN1; SMN2KMT2ARAB9AMAPTNPC1
SCHEMBL2526384 0.73 RXFP1 (0.49) ALDH1A1SMN1; SMN2KMT2ARAB9ATDP1
SCHEMBL12767872 0.73 KMT2A (0.72) ALDH1A1SMN1; SMN2KMT2ARAB9ATDP1
SCHEMBL584871 0.72 RXFP1 (0.71) ALDH1A1KMT2APKMNPSR1MAPT
SCHEMBL29939764 0.72 RXFP1 (0.71) ALDH1A1KMT2APKMNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 ALDH1A1 3135/4885SMN1; SMN2 2721/4885KMT2A 3013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback